Development of a conceptual model evaluating the humanistic and economic burden of Crohn’s disease: implications for patient-reported outcomes measurement and economic evaluation

作者: Adam Gater , Helen Kitchen , Louise Heron , Catherine Pollard , Jonas Håkan-Bloch

DOI: 10.1586/14737167.2015.1045883

关键词:

摘要: The primary objective of this review is to develop a conceptual model for Crohn’s disease (CD) outlining the burden patients, healthcare systems and wider society, as reported in scientific literature. A search was conducted using MEDLINE, PsycINFO, EconLit, Health Economic Evaluation Database Centre Reviews Dissemination databases. Patient-reported outcome (PRO) measures widely used CD were reviewed according US FDA PRO Guidance Industry. resulting highlights characterization by gastrointestinal disturbances, extra-intestinal systemic symptoms. These symptoms impact physical functioning, ability complete daily activities, emotional wellbeing, social sexual functioning work. Gaps coverage evidence reliability validity some noted. Review findings also highlight substantial direct indirect costs associated with CD. Evidence from literature con...

参考文章(103)
Jigneshkumar Patel, Thad Wilkins, Kathryn Jarvis, Diagnosis and management of Crohn's disease. American Family Physician. ,vol. 84, pp. 1365- 1375 ,(2011)
Francesc Casellas, Josefa López‐Vivancos, Alfonso Casado, Juan‐Ramon Malagelada, Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of Life Research. ,vol. 11, pp. 775- 781 ,(2002) , 10.1023/A:1020841601110
Dennis A. Revicki, Martha Wood, Ingela Wiklund, Joseph Crawley, Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease Quality of Life Research. ,vol. 7, pp. 75- 83 ,(1997) , 10.1023/A:1008841022998
E. Zambeli, M. Economou, S. Michopoulos, Incidence and prevalence of Crohn’s disease and its etiological influences Annals of Gastroenterology. ,vol. 22, pp. 158- 167 ,(2009)
Robert V. Bryant, Daniel R. van Langenberg, Gerald J. Holtmann, Jane M. Andrews, Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status Journal of Gastroenterology and Hepatology. ,vol. 26, pp. 916- 923 ,(2011) , 10.1111/J.1440-1746.2011.06624.X
S. Danese, J.-F. Colombel, W. Reinisch, P. J. Rutgeerts, Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience. Alimentary Pharmacology & Therapeutics. ,vol. 33, pp. 857- 869 ,(2011) , 10.1111/J.1365-2036.2011.04598.X
Gordon Guyatt, Alba Mitchell, E. Jan Irvine, Joel Singer, Nancy Williams, Robert Goodacre, Cathy Tompkins, A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease Gastroenterology. ,vol. 96, pp. 804- 810 ,(1989) , 10.1016/S0016-5085(89)80080-0
Dagmar Lühmann, Christian Brettschneider, Heiner Raspe, Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA). GMS health technology assessment. ,vol. 7, ,(2011) , 10.3205/HTA000092
M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett, P. J. Hamlin, Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience. Alimentary Pharmacology & Therapeutics. ,vol. 32, pp. 1357- 1363 ,(2010) , 10.1111/J.1365-2036.2010.04482.X
D A Drossman, J Leserman, Z M Li, C M Mitchell, E A Zagami, D L Patrick, The rating form of IBD patient concerns: a new measure of health status. Psychosomatic Medicine. ,vol. 53, pp. 701- 712 ,(1991) , 10.1097/00006842-199111000-00010